SCHEMBL6207026

SCHEMBL6207026

N/C(C(=O)c1ccccc1)=C(/F)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 11/20 0.52
CES1 P23141 11/20 0.52
TSHR P16473 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CYP2C19 P33261 2/20 0.48
POLB P06746 1/20 0.48
CYP3A4 P08684 1/20 0.48
PARP1 P09874 1/20 0.48
MAPT P10636 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
ALDH1A1 P00352 3/20 0.41
DAO P14920 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207030 1.00 CES2 (0.52) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6207035 0.83 CES2 (0.52) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6207820 0.78 CES2 (0.56) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6207823 0.78 CES2 (0.56) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL29664603 0.76 CES2 (0.59) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6207028 0.75 CES2 (0.52) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6206771 0.75 CES2 (0.52) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6205110 0.75 CES2 (0.56) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6205114 0.75 CES2 (0.56) CES2CES1TSHRL3MBTL1CYP2C19
SCHEMBL6206777 0.75 CES2 (0.52) CES2CES1TSHRL3MBTL1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed